MILAN — Fecal microbiota transplantation (FMT), also known as intestinal microbiota transplantation, significantly reduced recurrence of hepatic encephalopathy compared with placebo in patients with cirrhosis on […]

Despite the influx of adalimumab biosimilars entering the market in 2023, Humira remains on top. As of January 2024, both high and low concentrations of Humira, […]

The addition of abemaciclib to fulvestrant significantly improved progression-free survival for patients with hormone receptor positive, HER2 negative advanced breast cancer who had been previously treated […]

Liver transplantation plus chemotherapy significantly improves overall survival in carefully selected patients with unresectable colorectal liver metastases compared with chemotherapy alone, according to the results of […]

NASHVILLE, Tennessee — Large numbers of patients with multiple sclerosis (MS) who live outside large urban centers have little, or no, access to neurologic care, new […]

Adding durvalumab as consolidation treatment following concurrent chemoradiation (cCRT) adds 2 years of life and increases progression-free survival by 24% compared with placebo, in patients with […]

Among people diagnosed with cutaneous melanoma in the United States, those who live in rural areas have significantly lower rates of survival than those who live […]